INTRODUCTION 45
Central venous catheters (CVCs) are intravascular devices inserted centrally or 46 peripherally and terminate at the heart or in a proximal great vessel. CVCs are 47 indispensable tools in the acute hospital care and outpatient settings that enable infusion 48 therapy such as fluid management, i.v. administration of drugs, cancer 49 chemotherapeutics, hemodynamic monitoring, parenteral nutrition and hemodialysis. 50
CVCs enable continuous access to the central venous system without the need for 51 repeated venipuncture (1). 52 53 All intravascular catheters communicate with the vascular system and therefore must be 54 filled with a physiologically compatible solution to create a hydrostatic lock between the 55 catheter hub and the circulatory system. Lock solutions physically oppose the retrograde 56 flow of blood back into the indwelled catheter, however in doing so they support 57 microbial growth and biofilm formation inside catheters that are isolated from immune 58 surveillance. Biofilms are complex three-dimensional structures composed of 59 microorganisms living in a microbial generated extracellular matrix of proteins, nucleic 60 acids, and polysaccharides, and are characteristically less-susceptible to antimicrobial 61 agents (2, 3). Biofilms formed by bacteria (e.g. Staphylococcus aureus, S. epidermidis, 62
Pseudomonas aeruginosa and Acinetobacter spp.) as well as fungi (e.g. Candida 63 albicans) have the potential to go through cycles of active shedding, thus creating a nidus 64 of systemic pathogen dissemination that may be the cause of recurring blood stream 65 infections and sepsis (2 -9). 66 to $21.4 billion annually (18 
Biofilm formation 106
Early adhesion and mature phase biofilms were formed according to our standardized 107 protocol described previously (2, 4). Fungal and bacterial biofilms were grown on 108 silicone elastomer (SE) disks with a 1.5 cm diameter (Cardiovascular Instrument Corp., 109 Wakefield, Mass.). To facilitate biofilm growth and adhesion, sterile disks were placed 110 into 12 well tissue culture plates containing 2 mls of fetal bovine serum (FBS) each. 111
Plates were placed on a rocker and incubated for 24 h at 37°C. Disks were then removed 112 and washed with phosphate-buffered saline (PBS) to eliminate any remaining FBS. For 6 the formation of early (90 min) adhesion phase biofilms, FBS coated disks were then 114 soaked in 3 ml of 1 × 10 7 cells/ml and incubated for 90 minutes at 37°C. After 90 115 minutes, wells were gently washed with PBS to remove nonadherent cells. Following 116 adhesion phase biofilm formation, discs were incubated for 15, 30 or 60 min in the 117 presence of ACL (4 ml) or PBS control. 118
For the evaluation of activity against mature biofilms, bacterial and fungal cultures were 119 allowed to establish mature biofilms for an additional 24 h (bacteria) or 48 h (Candida). 120
Mature biofilms of bacteria and Candida were then exposed to 4 ml of phosphate 121 buffered saline (PBS) control or ACL for 2 and 4 h. 122 123
Activity of lock solution against microbial biofilms in vitro 124
At each time point, aliquots of adhesion and mature phase PBS treated control biofilms, 125 as well as and those exposed to ACL were harvested. SE discs were then scraped and the 126 scraped material was suspended in 100 µl. Ten-fold serial dilutions were made and 127 spread on PDA or BHI agar plates to enable microbial growth and obtain CFUs. Plates 128 were incubated for 24 h at 37°C and CFUs counted. Discs incubated with PBS alone, 129 were used as controls. 130 131
Efficacy of catheter lock solution in vivo 132
ACL was also tested against biofilms formed by C. albicans or MRSA in vivo using our 133 previously described rabbit lock therapy model (24) . A standard inoculum (300 µl) 134 consisting of 10 7 CFU/ml of C. albicans (M61) or MRSA (ATCC 43300) was prepared 135 in sterile normal saline with 100 U of heparin (Abbott Laboratories, North Chicago, IL). adhering to Institutional Animal Care and Use Committee guidelines. After the animals 139 were allowed to acclimatize for 7 days, surgery was performed to place a silicone 140 catheter in the external jugular vein. The catheters were made with silastic tubing cut to 141 30 cm, with an internal diameter of 0.04-in. and an external diameter of 0.085-in. (Dow 142
Corning, Midland, Mich.). To protect the catheter from collapse and ensure that it was 143 properly positioned, a polyethylene cuff (PE 240; Becton Dickinson, Sparks, Md.) was 144 slipped over the catheter and superglued 4 cm from the inserted end. Rabbits were 145 anesthetized intramuscularly using a cocktail of ketamine and xylazine prior to surgery. 146
The animals were clipped, and a surgical scrub was performed. Silicone catheters were 147 placed in the right external jugular vein and tunneled subcutaneously as described 148 previously (24) . Catheters were inoculated with 10 7 CFU/ml of C. albicans or MRSA, 149 which was 'locked' in the lumen of the catheter for 24 h to allow the formation of 150 intralumenal biofilm. Free floating organisms were then by aspirating the inoculum broth 151 and daily heparinized saline flushes, 100 U of heparin in sterile normal saline, were 152 performed for 3 days. Once mature biofilms were formed, blood samples were obtained 153 from the catheter and submitted for culture to confirm the presence of MRSA or C. 154 albicans. Animals inoculated with MRSA were randomized into the following groups: 1) 155 ACL lock therapy for 2 h/day for 7 days (n = 4), and 2) untreated control (n = 5). 156
Similarly, animals inoculated with C. albicans were randomized into the following 157 groups: 1) ACL lock therapy for 2 h/day for 7 days (n = 16), and 2) untreated control (n = 158 8). Untreated control catheters were flushed with heparinized saline daily.
After 159 completion of each daily treatment with ACL, the solution was removed and the ACL -160 treated catheters were flushed with 300 µl of heparinized saline. The animals were then 161 euthanized with a pentobarbital cardiac injection and the catheters removed for 162 quantitative culture and scanning electron microscopy (SEM) as described earlier (24) 
Activity of ACL against catheter-associated biofilms in vitro 186
The data demonstrate that ACL was able to prevent biofilm formation by resistant and 187 
